Ainos (AIMDW) reported second-quarter 2026 revenue of $152 and a net loss of $4.6 million for the quarter ended June 30, 2026. Net loss per common share was $0.62 on a basic and diluted basis.
The company also provided updates on AI Nose commercialization activity across semiconductor manufacturing, industrial infrastructure, robotics and healthcare-related environments.
- Second-quarter revenue was $152, compared with $4,663 in the year-earlier quarter.
- Net loss was $4.6 million, compared with a net loss of $4.1 million a year earlier.
- AI Nose has accumulated approximately 613 million industrial smell data records since December 2025, primarily from semiconductor manufacturing environments.
- Ainos advanced deployments tied to a previously announced initial $2.1 million commercial arrangement in backend semiconductor manufacturing environments.
- The company continued pilot programs in selected front-end semiconductor environments and expanded validation work in industrial and healthcare infrastructure settings.
$AIMDW Hedge Fund Activity
We have seen 1 institutional investors add shares of $AIMDW stock to their portfolio, and 1 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG removed 800 shares (-58.1%) from their portfolio in Q1 2026, for an estimated $92
- CLEAR STREET GROUP INC. added 1 shares (+0.0%) to their portfolio in Q1 2026, for an estimated $0
- BOOTHBAY FUND MANAGEMENT, LLC added 0 shares (+0.0%) to their portfolio in Q1 2026, for an estimated $0
- HEIGHTS CAPITAL MANAGEMENT, INC added 0 shares (+0.0%) to their portfolio in Q1 2026, for an estimated $0
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
